Autor: |
Farmakis IT; Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.; Department of Cardiology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Konstantinides SV; Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany Stavros.Konstantinides@unimedizin-mainz.de.; Department of Cardiology, Democritus University of Thrace, Alexandroupolis, Greece. |
Jazyk: |
angličtina |
Zdroj: |
The European respiratory journal [Eur Respir J] 2024 Aug 29; Vol. 64 (2). Date of Electronic Publication: 2024 Aug 29 (Print Publication: 2024). |
DOI: |
10.1183/13993003.01467-2024 |
Abstrakt: |
Competing Interests: Conflicts of interest: I.T. Farmakis has no potential conflicts of interest to disclose. S.V. Konstantinides reports personal lecture/advisory fees and research grants paid to institution from Bayer AG, Boston Scientific, Daiichi-Sankyo, LumiraDx, Penumbra and Inari Medical, and personal lecture/advisory fees from MSD, Pfizer and Bristol Myers Squibb. |
Databáze: |
MEDLINE |
Externí odkaz: |
|